MJ Biz reports…
Denmark’s medical cannabis pilot program notched another positive quarter, but the number of unique consumers remains well below the trial’s peak of a year ago.
The Danish market’s struggles demonstrate how businesses need to factor market ebbs and flows into their projections rather than counting on consistent, perpetual growth.
In the second quarter of 2020, the number of unique patients receiving a prescription for products included in the country’s pilot scheme was 408, more than the 341 reported in the previous quarter, according to data recently disclosed by the country’s official e-health portal.
Read full story at
